OGFR and neoplasm: Low-dose NTX carries out an intermittent OGFr blockade and OGF-OGFr axis upregulation activation which inhibits cell replication and has been reported to play a role in reducing tumor progression, [36•] whereas higher NTX doses cause continuous OGFr blockade, which results in enhanced cell growth [37].